Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial.

ABSTRACT:

Purpose

Lymphedema associated with head and neck cancer (HNC) therapy causes adverse clinical outcomes. Standard treatment includes professionally administered complete decongestive therapy (CDT). Cost and availability of trained therapists are known barriers to therapy. Advanced pneumatic compression devices (APCD) may address these issues. A randomized, wait-list controlled trial was undertaken to evaluate an APCD in post-treatment HNC patients with lymphedema.

Material and methods

Eligible patients had completed treatment for HNC, were disease free, and had lymphedema at enrollment. Participants were randomized to wait-list lymphedema self-management (standard of care) or lymphedema self-management plus the use of the APCD bid. Safety (CTCAE V4.0) and feasibility were pri

SUBMITTER: Ridner SH 

PROVIDER: S-EPMC7767900 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature